US FDA approves Gilead's twice-yearly injection for HIV prevention

FDA Approves First And Only Twice-Yearly PrEP Option

Source: YakubovAlim / Getty It has been a very long journey in the ongoing fight to end the HIV/AIDS epidemic, and now it appears we might be one step closer towards our goal with the FDA approval of Yeztugo. According to a new report by Gilead Sciences, Yeztugo (lenacapavir) will be the first and so far only option that gives people who need or want PrEP the option of injecting only twice a year. READ MORE STORIES FDA Approves First And Only Tw…

US approves twice-yearly injection for HIV prevention – what you need to know about lenacapavir

The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection against HIV infection. Administered once every six months, this new treatment marks a major advancement in expanding prevention options for people at risk of HIV infection. Most HIV prevention drugs are daily pills (known as PrEP), which many people struggle to take regularly for various reasons, including inconvenience, pri…

CryoET structures of immature HIV Gag reveal six-helix bundle

Gag is the HIV structural precursor protein which is cleaved by viral protease to produce mature infectious viruses. Gag is a polyprotein composed of MA (matrix), CA (capsid), SP1, NC (nucleocapsid), SP2 and p6 domains. SP1, together with the last eight residues of CA, have been hypothesized to form a six-helix bundle responsible for the higher-order multimerization of Gag necessary for HIV particle assembly. However, the structure of the comple…

Linda Boyle: Warp speed changes in FDA policy

By LINDA BOYLE The era of the Federal Drug Administration just rubberstamping whatever the pharmaceutical companies send in for the next Covid booster jab is over.  Gone are the days when a booster can be approved for anyone over six months of age when it was only tested on eight mice.  No longer will boosters be […] The post Linda Boyle: Warp speed changes in FDA policy appeared first on Must Read Alaska.

U.S. approves first-ever biannual shot to prevent HIV, but getting it might be hard

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.

FDA Approves PrEP Drug Requiring Only Two Injections Per Year

FDA approves PrEP drug. Lenacapavir is a twice-yearly HIV prevention shot more effective than daily pills. The post FDA Approves PrEP Drug Requiring Only Two Injections Per Year appeared first on Metro Weekly.